EFG Asset Management North America Corp. Sells 9,056 Shares of Doximity, Inc. (NASDAQ:DOCS)

EFG Asset Management North America Corp. reduced its position in Doximity, Inc. (NASDAQ:DOCSFree Report) by 13.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 57,920 shares of the company’s stock after selling 9,056 shares during the period. EFG Asset Management North America Corp.’s holdings in Doximity were worth $3,092,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Global Retirement Partners LLC increased its position in Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after purchasing an additional 440 shares during the period. UMB Bank n.a. boosted its stake in shares of Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. Larson Financial Group LLC grew its position in shares of Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after buying an additional 250 shares during the period. Optimum Investment Advisors bought a new stake in shares of Doximity during the fourth quarter worth approximately $43,000. Finally, Morse Asset Management Inc acquired a new position in Doximity in the third quarter valued at approximately $46,000. Institutional investors own 87.19% of the company’s stock.

Insider Activity at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares of the company’s stock, valued at $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 37.40% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Mizuho lifted their target price on shares of Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Leerink Partnrs raised Doximity from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 7th. The Goldman Sachs Group upped their price objective on Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Finally, Bank of America upped their price target on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Doximity currently has a consensus rating of “Moderate Buy” and an average price target of $64.22.

Read Our Latest Research Report on DOCS

Doximity Price Performance

DOCS opened at $66.39 on Tuesday. The company has a market capitalization of $12.39 billion, a price-to-earnings ratio of 66.39, a P/E/G ratio of 4.10 and a beta of 1.34. The business’s 50-day moving average price is $64.76 and its two-hundred day moving average price is $53.85. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21.

About Doximity

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.